Article
An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs.
Biochemistry - 26 Aug 2003
McDonald J F, Dimitry J M, Frazier W A
Abstract excerpt
Two VVM-containing peptides in the C-terminal domain (CBD) of thrombospondin-1 function as CD47 agonists. A recombinant form of the CBD (rCBD) has been expressed that contains both VVM sites and exhibits CD47-dependent binding of C32 melanoma cells when coated at concentrations 100x lower than th...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
